Similar Items: Development and evaluation of a recombinant vaccine against Clostridium perfringens type D epsilon toxin
- The beta-toxin of Clostridium welchii type B, Wilsdon, in relation to the production of a vaccine against lamb dysentery
- Performance of Clostridium perfringens-challenged broilers inoculated with effective microorganisms
- Preliminary investigations into the immunity of ostriches to Newcastle disease and Clostridium perfringens infections
- Effects of feed additives on gut microbial diversity of Clostridium perfringens challenged broilers
- Molecular Characterisation Of Clostridium Perfringens Isolates From Patients At Groote Schuur Hospital
- Development of recombinant vaccines against foot-and-mouth disease
Author: Theron, Jacques
- Characterization of genetic elements up-regulated in Pseudomonas aeruginosa PAO biofilms and transcriptional activity of the flagellar hook protein gene, flgE, during biofilm development
- Evaluation of thermally regulated promoter systems for use in Escherichia coli and Bacillus subtilis
- Expression of the botulinum neurotoxin serotype D binding domain in Brevibacillus brevis and its evaluation as a candidate vaccine antigen in mice
- Proteomic analysis of the biofilm and biofilm-associated phenotypes of Pseudomonas aeruginosa cultured in batch
- Identification of viral proteins and cellular pathways involved in the induction of apoptosis of African horse sickness virus-infected mammalian cells
- Importance of an arginine-glycine-aspartic acid (RGD) motif in the VP7 protein of African horse sickness virus to mediate insect cell binding